Eicosanoids and the stomach (Q33950285)

30 July 2017

1 reference

title

Eicosanoids and the stomach (English)

1 reference

30 July 2017

Atay S

1

1 reference

PubMed ID

10867124

30 July 2017

Tarnawski AS

series ordinal

2

1 reference

PubMed ID

10867124

30 July 2017

Dubois A

series ordinal

3

1 reference

30 July 2017

1 May 2000

1 reference

Prostaglandins and Other Lipid Mediators

30 July 2017

1 reference

30 July 2017

61

1 reference

30 July 2017

3-4

1 reference

30 July 2017

105-124

1 reference

Eicosanoids and the gastrointestinal tract

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Prostaglandin endoperoxide synthase: structure and catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Nitric oxide activates cyclooxygenase enzymes.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Inhibition of gastric secretion by prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Gastric antisecretory effects of E prostaglandins in Rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

The effect of intravenous infusions of prostaglandins E-2 and F-2alpha on human gastric function

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

A comparison of the effects of prostacyclin and the 15(S), 15-methyl analogs of PGE2 and PGF2-alpha on gastric parietal and nonparietal secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Prostaglandins: Their Disappearance from and Release into the Circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Electrical and mechanical properties of longitudinal and circular muscles of the guinea-pig ileum

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

The cellular and molecular basis of gastric mucosal defense.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Gastroduodenal mucosal protection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Gastroduodenal ulceration following active immunization with prostaglandin E2 in dogs. Role of gastric acid secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Role of endogenous prostaglandins in preventing gastrointestinal ulceration: induction of ulcers by antibodies to prostaglandins.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Apoptosis, the heat shock response, hyperthermia, birth defects, disease and cancer. Where are the common links?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

The effect of phospholipase A2 inhibitors on proliferation and apoptosis of murine intestinal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Effects of NSAIDs on proliferation of gastric cancer cells in vitro: possible implication of cyclooxygenase-2 in cancer development

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Induction of apoptotic DNA fragmentation by nonsteroidal anti-inflammatory drugs in cultured rat gastric mucosal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Induction of tumor necrosis factor-alpha and apoptosis in gastric mucosal injury by indomethacin: effect of omeprazole and ebrotidine

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Mechanisms of mucosal injury and healing: the role of non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Prostaglandin protection of human isolated gastric glands against indomethacin and ethanol injury. Evidence for direct cellular action of prostaglandin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Role of prostaglandin E2 on human gastric ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Endogenous prostaglandin E2 in gastric mucosa of patients with alcoholic cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Role of prostaglandin E2 on gastric ulcers induced by non-steroidal anti-inflammatory compounds (NOSAC)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Secretagogues stimulate prostaglandin synthesis and inhibit mucosal damage induced by a necrotizing agent in rat gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

In vitro adaptive cytoprotection in gastric cells isolated from rat stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Prostaglandin-induced protection of cultured rat gastric cells against ethanol is inhibited by a microtubule inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Induction of HSP70 gene expression by the antiproliferative prostaglandin PGA2: a growth-dependent response mediated by activation of heat shock transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Association of 72-kDa heat shock protein expression with adaptation to aspirin in rat gastric mucosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Antiproliferative prostaglandins activate heat shock transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Heat shock proteins and virus replication: hsp70s as mediators of the antiviral effects of prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Inhibition of heat-shock protein 70 induction in intestinal cells overexpressing cyclooxygenase 2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Temporal relationships between stress protein induction, progesterone withdrawal, and apoptosis in corpora lutea of ewes treated with prostaglandin F2 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Pathogenesis of gastroduodenal injury due to nonsteroidal antiinflammatory drugs: implications for prevention and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Effect of acetylsalicylic acid on gastric mucin viscosity, permeability to hydrogen ion, and susceptibility to pepsin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Indomethacin inhibits duodenal mucosal bicarbonate secretion and endogenous prostaglandin E2 output in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

NSAIDs, gastrointestinal injury, and cytoprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Duodenal acidification and secretin, but not intraduodenal fat, inhibit human gastric acid secretion via prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

A monoclonal antibody against the CD18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

The 1994 Merck Frosst Award. Mechanisms of nonsteroidal anti-inflammatory drug (NSAID) induced gastrointestinal damage--potential for development of gastrointestinal tract safe NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Nonsteroidal anti-inflammatory drugs and peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Efficacy of 12 months' misoprostol as prophylaxis against NSAID-induced gastric ulcers. A placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Interaction of cyclooxygenases with an apoptosis- and autoimmunity-associated protein

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Immunocytochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the rat stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Aspirin causes rapid up-regulation of cyclo-oxygenase-2 expression in the stomach of rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Constitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Levels of cyclooxygenase-1 and -2 mRNA expression at various stages of acute gastric injury induced by ischemia-reperfusion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Expression of the cyclooxygenase-2 gene in gastric epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Induction of cyclooxygenase-2 in a rat gastric epithelial cell line by epiregulin and basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Cyclooxygenases-1 and −2 of Endothelial Cells Utilize Exogenous or Endogenous Arachidonic Acid for Transcellular Production of Thromboxane

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Cyclooxygenase-2 as a therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Angiogenesis in gastric ulcers: impaired in patients taking non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Expression of cyclooxygenase 1 and 2 by human gastric endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Gastric effects of leukotrienes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Leukotrienes C4, D4 and E4 cause widespread and extensive plasma extravasation in the guinea pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Vascular injury in acute gastric mucosal damage. Mediatory role of leukotrienes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Investigation of the vascular actions of arachidonate lipoxygenase and cyclo-oxygenase products on the isolated perfused stomach of rat and rabbit.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Evidence for differing leukotriene receptors in gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

Effects of non-steroidal anti-inflammatory drugs on rat gastric mucosal leukotriene C4 and prostanoid release: relation to ethanol-induced injury

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2800%2900067-8

7 January 2021

10.1016/S0090-6980(00)00067-8

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10867124